UPA Femara 2.5mg (Letrozole)

UPA Femara 2.5mg is an oral product listed as containing Letrozole, a potent non-steroidal aromatase inhibitor (AI). Each pack contains 30 tablets, with a stated strength of 2.5mg per tablet.

Letrozole works by reducing the body's production of oestrogen through inhibition of the aromatase enzyme. It is primarily used in medical settings for the treatment of certain hormone-sensitive breast cancers in postmenopausal women.

Letrozole has also been investigated for its effects on reproductive hormone regulation and is sometimes prescribed off-label for ovulation induction in women experiencing certain fertility-related conditions.

In bodybuilding communities, Letrozole is sometimes associated with managing elevated oestrogen levels during anabolic steroid use. However, this application is not medically approved, and excessive oestrogen suppression can cause significant health complications.

What UPA Femara Is Used For

Letrozole is a non-steroidal aromatase inhibitor primarily used in medical settings to reduce oestrogen production in hormone-sensitive conditions.

Its recognised applications and pharmacological effects include:

• Oestrogen Reduction: Reduces circulating oestrogen levels by inhibiting the aromatase enzyme responsible for oestrogen synthesis.
• Hormone-Sensitive Breast Cancer: Used in the treatment of certain oestrogen receptor-positive breast cancers in postmenopausal women.
• Aromatisation Inhibition: Blocks the conversion of androgens into oestrogens through the aromatase pathway.
• Hormonal Regulation: Influences circulating oestrogen concentrations and the body's reproductive hormone feedback mechanisms.
• Ovulation Induction: Sometimes prescribed off-label to stimulate ovulation in women experiencing certain fertility-related conditions.
• Polycystic Ovary Syndrome (PCOS): Used under medical supervision for ovulation induction in selected women with PCOS.
• Oestrogen-Dependent Tissue Activity: Reduces oestrogen stimulation in tissues affected by circulating oestrogen levels.
• Elevated Oestrogen Management: May be prescribed in selected clinical circumstances involving excessive oestrogen production, although use in men is generally off-label.

Important: Letrozole is not an anabolic steroid and does not directly stimulate muscle growth. Its primary effects are associated with reducing oestrogen production.

How UPA Femara Works

Letrozole belongs to a class of medications known as non-steroidal aromatase inhibitors.

It works by inhibiting the aromatase enzyme, which is responsible for converting certain androgens, including testosterone and androstenedione, into oestrogens.

By blocking this conversion process, Letrozole reduces circulating oestrogen concentrations and limits oestrogen-related signalling in hormone-sensitive tissues.

Its primary mechanisms include:

• Aromatase Inhibition: Blocks the aromatase enzyme responsible for converting androgens into oestrogens.
• Reduced Oestrogen Production: Decreases circulating oestrogen concentrations by limiting their synthesis.
• Hormonal Feedback Regulation: Influences reproductive hormone feedback mechanisms associated with circulating oestrogen levels.
• Oestrogen-Dependent Tissue Activity: Reduces oestrogen stimulation in tissues that respond to oestrogen signalling.
• Non-Steroidal Activity: Inhibits aromatase without acting as an anabolic steroid or directly blocking oestrogen receptors.
• Ovulation-Related Hormonal Effects: In certain women, reduced oestrogen feedback can increase follicle-stimulating hormone (FSH) activity, supporting ovarian follicle development.
• Androgen-to-Oestrogen Conversion: Reduces the conversion of testosterone and other aromatisable androgens into oestrogens.
• Systemic Oestrogen Suppression: Can produce substantial reductions in oestrogen levels throughout the body.

Unlike Selective Oestrogen Receptor Modulators (SERMs), such as Clomiphene or Tamoxifen, Letrozole does not primarily work by blocking oestrogen receptors. Instead, it reduces the production of oestrogen itself.

Possible Side Effects

Letrozole may cause adverse effects associated with reduced oestrogen levels and changes in hormonal regulation. Side effects can vary depending on individual sensitivity, treatment duration and underlying medical conditions.

Common or Recognised Side Effects:

• Hot flushes and increased sweating.
• Joint pain, stiffness or discomfort.
• Muscle aches and general body discomfort.
• Headaches.
• Fatigue or weakness.
• Dizziness or light-headedness.
• Nausea or gastrointestinal discomfort.
• Difficulty sleeping or insomnia.
• Mood changes or depressive symptoms.
• Reduced libido.
• Vaginal dryness in women.
• Hair thinning or hair loss.